Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Specific Targeting of Brain Tumors with an Optical/Magnetic Resonance Imaging Nanoprobe across the Blood-Brain Barrier
Cancer Research, 08/03/09
Veiseh O et al. – With the versatile affinity of the targeting ligand and the flexible conjugation chemistry for alternative diagnostic and therapeutic agents, this nanoparticle platform can be potentially used for the diagnosis and treatment of a variety of tumor types.
Related Articles
Brain Tumor Survivors Speak Out
Journal of Pediatric Oncology Nursing, 10/26/09
Relevance Score: 70%
Immunotherapy of pediatric brain tumor patients should include an immunoprevention strategy: a medical hypothesis paper
Journal of Neuro-Oncology, 10/26/09
Relevance Score: 70%
Endocrine Late Effects in Survivors of Pediatric Brain Tumors
Journal of Pediatric Oncology Nursing, 10/26/09
Relevance Score: 69%
Convection-enhanced delivery for the treatment of brain tumors
Expert Review of Neurotherapeutics, 10/21/09
Relevance Score: 69%
Assessment of total sialic acid and lipid-bound sialic acid in management of brain tumors
Annals of the Indian Academy of Neurology, 10/16/09
Relevance Score: 69%
Today in Diagnostics/Radiology...keeping you current
Receive free subspecialty "5-minute updates" via email
Significance of Signet-ring cells seen in exfoliative and aspiration cytopathology
Diagnostic Cytopathology, 12/02/09
A rare case of pulmonary cryptococcal inflammatory myofibroblastic tumor diagnosed by fine needle aspiration cytology
Diagnostic Cytopathology, 12/02/09
Today in Neurologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
FDA Drug Approval Summary: Bevacizumab (Avastin) as Treatment of Recurrent Glioblastoma Multiforme
The Oncologist, 12/02/09
Most primary central nervous system diffuse large B-cell lymphomas occurring in immunocompetent individuals belong to the nongerminal center subtype: a retrospective analysis of 31 cases
Modern Pathology, 12/02/09
KIR and HLA Genotypes Are Associated with Disease Progression and Survival following Autologous Hematopoietic Stem Cell Transplantation for High-Risk Neuroblastoma
Clinical Cancer Research, 12/01/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


